The abstract is read at the publisher; the summary is JClub's.
Neural repair therapies after stroke aim to enhance plasticity in surviving brain tissue, and trial design principles—selection, timing, outcomes, and biomarkers—are expected to improve functional recovery.
- Why it matters: Acute injury–focused treatments alone have not been sufficient to improve outcomes, so repair-based approaches require careful clinical-trial structure to detect real benefits.
- What they did: This review synthesizes key stroke recovery trials to outline principles for patient selection, control-group design, intervention timing, outcome selection, experience-dependent plasticity, biomarker use, and statistical considerations.
- The result: Incorporating neuroimaging/neurophysiology biomarkers for target viability, using modality-specific outcomes, and aligning therapy timing and experience intensity/type with plasticity windows should improve neural repair trial design and interpretation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.